Relevant aspects of hypofractionation in breast and prostate radiotherapy
DOI:
https://doi.org/10.33448/rsd-v10i5.14904Keywords:
Cancer; Breast cancer; Prostate cancer; Radiotherapy; Radiobiology.Abstract
Objective: to discuss the most relevant and beneficial aspects of hypofractionation in breast and prostate radiotherapy, which correspond to the most frequent types of cancers in women and men, respectively, except for non-melanoma skin cancer. Method: An integrative literature review was carried out on important points of hypofractionation in breast and prostate radiotherapy, where articles were selected using the MEDLINE, PUBMED, LILACS, SciELO and Google Scholar platforms, choosing to compose the sample space of the review only published articles from the year 2011. In the choice of articles, those that contained long-term results with a good number of patients, such as meta-analysis, were analyzed. Results: Knowing that in the radiotherapy with hypofractionation, the number of fractions is reduced, the patient can be favored in several aspects, such as the reduction of the treatment period, less exposure to ionizing radiation, advantage in relation to the side effects and, mainly, in the context of the COVID-19 pandemic, hypofractionation can benefit many patients with less trips to the hospital environment.
References
Araujo, S. E. A., Leal, A., Centrone, A. F. Y., Teich, V. D., Malheiro, D. T., Cypriano, A. S., Cendoroglo Neto, M., & Klajner, S.. (2021). Impacto da COVID-19 sobre o atendimento de pacientes oncológicos: experiência de um centro oncológico localizado em um epicentro Latino-Americano da pandemia. Einstein (São Paulo), 19, eAO6282. https://doi.org/10.31744/einstein_journal/2021ao6282.
Bruner, D. W., Pugh, S. L., Lee, W. R, Hall, W. A., Dignam, J. J., Low, D., Swanson, G. P., Shah, A. B., Malone, S., Michalski, J. M., Dayes, I. S., Seaward, S. A., Nguyen, P. L., Pisansky, T. M., Chen, Y., Sandler, H. M., & Movsas, B. (2019). Quality of life in patients with low-risk prostate cancer treated with hypofractionated vs conventional radiotherapy: a phase 3 randomized clinical trial. JAMA Oncology, 5(5), 664–670. https://doi: 10.1001/jamaoncol.2018.6752.
Brunt, A. M., Haviland, J. S., Wheatley, D. A., Sydenham, M. A., Alhasso, A., Bloomfield, D. J., Chan, C., Churn, M., Cleator, S., Coles, C. E., Goodman, A., Harnett, A., Hopwood, P., Kirby, A. M., Kirwan, C. C., Morris, C., Nabi, Z., Sawyer, E., Somaiah, N., Stones, L., Syndikus, I., Bliss, J. M., & Yarnold, J. R. (2020). FAST-Forward Trial Management Group. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet, 395(10237), 1613–1626. https://doi:10.1016/S0140-6736(20)30932-6.
Cury, F. L. B., & Souhami, L. (2004). Hipofracionamento no câncer de próstata. Revista Brasileira de Cancerologia, 50(3), 239–249.
Diegues, S. S., Ciconelli, R. M., & Segreto, R. A. (2008). Causas de interrupção não-programadas da radioterapia. Radiologia Brasileira, 41(2), 103–108.
Estrela, C. (2018). Metodologia científica: ciência, ensino, pesquisa. 3. ed. Porto Alegre: Artes Médicas.
Freitas, N. M. A., Rosa, A. A., Marta, G. N., Hanna, S. A., Hanriot, R. M., Borges, A. B. B., Gondim, G. R. M., Pellizzon, A. C. A., Veras, I. M., Almeida Jr., W. J., Fernandez, C. R. S. H. W., Batalha Filho., E. S., Castilho, M. S., Kuhnen, F. Q., Najas, R. M. X. F., Affonso Jr., R. J., Leite, A. C. C., Ribeiro, H. L. M., Freitas Jr., R., & Oliveira, H. F. (2018). Recommendations for hypofractionated whole-breast irradiation. Revista da Associação Médica Brasileira, 64(9), 770–777. https://doi.org/10.1590/1806-9282.64.09.770.
Guimarães, R. (2016). Quando menos é mais. Rede Câncer, 35, 19–21.
Hall, E. J., & Giaccia, A. J. (2006). Radiobiology for the radiologist. 6. ed. Philadelphia: Ed. Lippincott Williams & Wilkins.
Haviland, J. S., Owen, J. R., Dewar, J. A., Agrawal, R. K., Barrett, J., Barrett-Lee, P. J., Dobbs, H. J., Hopwood, P., Lawton, P. A., Magee, B. J., Mills, J., Simmons, S., Sydenham, M. A., Venables, K., Bliss, J. M., Yarnold, J. R., & START Trialists' Group. (2013). The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. The Lancet Oncology, 14(11), 1086–1094. https://doi.org/10.1016/S1470-2045(13)70386-3.
INCA. Instituto Nacional de Câncer. (2020). Ministério da Saúde. Estatísticas de câncer. Disponível em https://www.inca.gov.br/numeros-de-cancer. Acesso: 14 de mar. 2021.
INCA. Instituto Nacional de Câncer. (2000). Ministério da Saúde. Manual para técnicos em radioterapia. Rio de Janeiro: INCA.
Krug, D., Baumann, R., Combs, S. E., Duma, M. N., Dunst. J. Feyer, P., Fietkau, R., Haase, W., Harms, W., Hehr, T., Piroth, M. D., Sedlmayer, F., Souchon, R., Strnad, V., & Budach, W. (2021). Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: considerations regarding FAST and FAST-Forward. Strahlentherapie und Onkologie, 28, 1–12. https://doi.org/10.1007/s00066-020-01744-3.
Kuderer, N. M., Choueiri, T. K., Shah, D. P., Shyr, Y., Rubinstein, S. M., Rivera, D. R., Shete, S., Hsu, C. Y., Desai, A., de Lima Lopes, G., Jr, Grivas, P., Painter, C. A., Peters, S., Thompson, M. A., Bakouny, Z., Batist, G., Bekaii-Saab, T., Bilen, M. A., Bouganim, N., Larroya, M. B., Castellano, D., Del Prete, S. A., Doroshow, D. B., Egan, P. C., Elkrief, A., Farmakiotis, D., Flora, D., Galsky, M. D., Glover, M. J., Griffiths, E. A., Gulati, A. P., Gupta, S., Hafez, N., Halfdanarson, T. R., Hawley, J. E., Hsu, E., Kasi, A., Khaki, A. R., Lemmon, C. A., Lewis, C., Logan, B., Masters, T., McKay, R. R., Mesa, R. A., Morgans, A. K., Mulcahy, M. F., Panagiotou, O. A., Peddi, P., Pennell, N. A., Reynolds, K., Rosen, L. R., Rosovsky, R., Salazar, M., Schmidt, A., Shah, S. A., Shaya, J. A., Steinharter, J., Stockerl-Goldstein, K. E., Subbiah, S., Vinh, D. C., Wehbe, F. H., Weissmann, L. B., Wu, J. T., Wulff-Burchfield, E., Xie, Z., Yeh, A., Yu, P. P., Zhou, A. Y., Zubiri, L., Mishra, S., Lyman, G. H., Rini, B. I., Warner, J. L., & COVID-19 and Cancer Consortium (2020). Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet (London, England), 395(10241), 1907–1918. https://doi.org/10.1016/S0140-6736(20)31187-9.
Lee, W. R., Dignam, J. J., Amin, M. B., Bruner, D. W., Low, D., Swanson, G. P., Shah, A. B., D'Souza, D. P., Michalski, J. M., Dayes, I. S., Seaward, S. A., Hall, W. A., Nguyen, P. L., Pisansky, T. M., Faria, S. L., Chen, Y., Koontz, B. F., Paulus, R., & Sandler, H. M. (2016). Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer. Journal of Clinical Oncology, 34(20), 2325–2332. https://doi.org/10.1200/JCO.2016.67.0448.
Lüdke, M., & André, M. E. D. A. (1986). Pesquisa em educação: abordagens qualitativas. São Paulo: EPU.
Marta, G. N. (2014). Radiobiologia: princípios básicos aplicados à prática clínica. Diagnóstico & Tratamento, 19(1), 45–47.
Nahum, A. E. (2015). The radiobiology of hypofractionation. Clinical Oncology, 27, 260–269.
Nascimento, M. I., & Silva, G. A. (2015). Efeito do tempo de espera para radioterapia na sobrevida geral em cinco anos de mulheres com câncer do colo do útero, 1995-2010. Cadernos de Saúde Pública, 31(11), 2437–2448.
Okuno, E., & Yoshimura, E. M. (2010). Física das radiações. São Paulo: Oficina de Textos.
SBRT. Sociedade Brasileira de Radioterapia. (2018). Hipofracionamento é tema da primeira mesa redonda do XX Congresso da SBRT. Disponível em https://sbradioterapia.com.br /congresso-sbrt-2018/hipofracionamento-e-tema-da-primeira-mesa-redonda-do-xx-congresso-da-sbrt/. Acesso em: 24 de jan. 2021.
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA: A Cancer Journal for Clinicians, 0, 1–41. https://doi: 10.3322/caac.21660.
Wang, S. L., Fang, H., Song, Y. W., Wang, W. H., Hu, C., Liu, Y. P., Jin, J., Liu, X. F., Yu, Z. H., Ren, H., Li, N., Lu, N. N., Tang, Y., Tang, Y., Qi, S. N., Sun, G. Y., Peng, R., Li, S., Chen, B., Yang, Y., & Li, Y. X. (2019). Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. The Lancet. Oncology, 20(3), 352–360. https://doi.org/10.1016/S1470-2045(18)30813-1.
Weller, W., & Pfaff, N. (Orgs.). (2011). Metodologias da pesquisa qualitativa em educação: teoria e prática. 2. ed. Petrópolis: Vozes.
Whelan, T. J., Pignol, J. P., Levine, M. N., Julian, J. A., MacKenzie, R., Parpia, S., Shelley, W., Grimard, L., Bowen, J., Lukka, H., Perera, F., Fyles, A., Schneider, K., Gulavita, S., & Freeman, C. (2010). Long-term results of hypofractionated radiation therapy for breast cancer. The New England journal of medicine, 362(6), 513–520. https://doi.org/10.1056/NEJMoa0906260.
Widmark, A., Gunnlaugsson, A., Beckman, L., Thellenberg-Karlsson, C., Hoyer, M., Lagerlund, M., Kindblom, J., Ginman, C., Johansson, B., Björnlinger, K., Seke, M., Agrup, M., Fransson, P., Tavelin, B., Norman, D., Zackrisson, B., Anderson, H., Kjellén, E., Franzén, L., & Nilsson, P. (2019). Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial. Lancet (London, England), 394(10196), 385–395. https://doi.org/10.1016/S0140-6736(19)31131-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Laélia Campos; Joyce Rezende Santos; Divanizia do Nascimento Souza; Márcia Regina Pereira Attie
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
